Apellis Pharmaceuticals (APLS) Insider Trading & Ownership $27.52 -0.83 (-2.93%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$27.52 0.00 (0.00%) As of 02/21/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$30.62 M Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLS Insider Buying and Selling by Quarter Apellis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/11/2025Mark Jeffrey DelongInsiderSell363$28.54$10,360.02 1/29/2025Cedric FrancoisCEOSell2,824$29.52$83,364.48 1/29/2025David O WatsonGeneral CounselSell695$29.52$20,516.40 1/29/2025Nur NicholsonInsiderSell825$29.52$24,354.00 1/29/2025Timothy Eugene SullivanCFOSell546$29.52$16,117.92 1/22/2025Cedric FrancoisCEOSell13,551$30.43$412,356.93 1/22/2025David O WatsonGeneral CounselSell3,323$30.43$101,118.89 1/22/2025James George ChopasCAOSell1,096$30.43$33,351.28 1/22/2025Nur NicholsonInsiderSell3,948$30.43$120,137.64 1/22/2025Timothy Eugene SullivanCFOSell3,088$30.43$93,967.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/17/2025Cedric FrancoisCEOSell6,007$29.96$179,969.72 1/17/2025David O WatsonGeneral CounselSell2,201$29.96$65,941.96 1/17/2025James George ChopasCAOSell715$29.96$21,421.40 1/17/2025Nur NicholsonInsiderSell2,145$29.96$64,264.20 1/17/2025Timothy Eugene SullivanCFOSell1,730$29.96$51,830.80 1/13/2025Cedric FrancoisCEOSell6,247$28.70$179,288.90 1/13/2025David O WatsonGeneral CounselSell4,965$28.70$142,495.50 1/13/2025James George ChopasCAOSell783$28.70$22,472.10 1/13/2025Jeffrey EiseleInsiderSell264$28.70$7,576.80 1/13/2025Timothy Eugene SullivanCFOSell2,170$28.70$62,279.00 1/6/2025Caroline BaumalInsiderSell2,816$33.81$95,208.96 12/23/2024Jeffrey EiseleInsiderSell63$33.09$2,084.67 9/16/2024A. Sinclair DunlopDirectorSell37,000$36.23$1,340,510.00 6/21/2024A. Sinclair DunlopDirectorSell37,000$39.24$1,451,880.00 5/8/2024Pascal DeschateletsInsiderSell78,907$42.35$3,341,711.45 4/8/2024Pascal DeschateletsInsiderSell69,107$54.17$3,743,526.19 4/1/2024Timothy Eugene SullivanCFOSell4,000$58.66$234,640.00 3/19/2024A. Sinclair DunlopDirectorSell18,681$57.18$1,068,179.58 3/18/2024Mark Jeffrey DelongInsiderSell9,913$56.90$564,049.70 3/15/2024James George ChopasCAOSell184$56.46$10,388.64 3/13/2024Nur NicholsonInsiderSell11,220$57.56$645,823.20 3/1/2024Cedric FrancoisCEOSell250,000$64.11$16,027,500.00 3/1/2024Timothy Eugene SullivanCFOSell6,000$63.22$379,320.00 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals's Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Nur Nicholson, Pascal Deschatelets, Timothy Eugene Sullivan, and Victoria L Brown. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 6.80% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,897,594.58), Adam J Townsend ($713,194.96), Alec Machiels ($716,900.00), Caroline Baumal ($260,406.51), Cedric Francois ($32,149,975.10), David O Watson ($1,985,559.31), James George Chopas ($243,117.27), Jeffrey Eisele ($156,037.69), Karen Lewis ($805,000.00), Lukas Scheibler ($600,000.00), Mark Jeffrey Delong ($580,440.96), Nur Nicholson ($1,809,030.44), Pascal Deschatelets ($13,858,877.64), and Timothy Eugene Sullivan ($8,121,551.61). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 1,139,903 Apellis Pharmaceuticals shares in the last 24 months for a total of $65,897,686.07 sold. Apellis Pharmaceuticals Key ExecutivesDr. Cedric Francois M.D. (Age 52)Ph.D., Co-Founder, President, CEO & Director Compensation: $1.44MMr. Alec Machiels J.D. (Age 51)MBA, Co-Founder & Director Compensation: $90.62kMr. Timothy E. Sullivan (Age 53)CFO & Treasurer Compensation: $793.43k4 recent tradesMr. Adam J. Townsend (Age 46)Chief Operating Officer Compensation: $770.44kMr. David O. Watson Esq. (Age 51)J.D., General Counsel Compensation: $764.37k4 recent tradesDr. Caroline R. Baumal M.D. (Age 56)Chief Medical Officer Compensation: $1.01MDr. Pascal Deschatelets Ph.D. (Age 54)Co-Founder & Chief Scientific Officer Compensation: $688.05kMr. James G. Chopas CPA (Age 57)VP, Corporate Controller & Chief Accounting Officer Ms. Meredith KayaSenior Vice President, Investor Relations & Strategic FinanceMs. Karen Lewis (Age 51)Chief People Officer More Insider Trading Tools from MarketBeat Related Companies Intra-Cellular Therapies Insider Transactions Viatris Insider Transactions Moderna Insider Transactions Vaxcyte Insider Transactions Sarepta Therapeutics Insider Transactions Roivant Sciences Insider Transactions Revolution Medicines Insider Transactions BridgeBio Pharma Insider Transactions Axsome Therapeutics Insider Transactions Blueprint Medicines Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:APLS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
